Form 4: Tenon Medical CFO Converts RSUs, Sells Shares for Tax

Sentiment:

Insider Transaction Report


Tenon Medical's CFO, Kevin Williamson, converted 58,987 restricted stock units into common stock and subsequently sold 18,518 shares to cover tax liabilities.

Summary

  • Kevin Williamson, Chief Financial Officer and Director of Tenon Medical, Inc. (TNON), reported changes in his beneficial ownership.
  • On January 1, 2026, 58,987 restricted stock units (RSUs), which were granted on October 13, 2025, converted into 58,987 shares of Tenon Medical common stock.
  • Following the RSU conversion, Williamson's beneficial ownership of common stock was 61,070 shares.
  • On January 5, 2026, Williamson disposed of 18,518 shares of common stock at a price of $0.9312 per share.
  • These shares were sold specifically to satisfy tax liabilities associated with the vesting of the restricted stock units.
  • After these reported transactions, Williamson beneficially owns 42,552 shares of Tenon Medical common stock.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions involving the vesting of restricted stock units and subsequent sale of shares to cover tax liabilities, which is a common occurrence for executive compensation and does not indicate a significant positive or negative shift in company outlook.

Positives

  • The vesting of 58,987 restricted stock units for CFO Kevin Williamson represents a successful milestone in his executive compensation plan.

Negatives

  • CFO Kevin Williamson sold 18,518 shares of common stock, which reduces his direct ownership stake in the company.
  • The sale price of $0.9312 per share for the tax-related disposition reflects the market value at the time of the transaction.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • The conversion of restricted stock units (RSUs) into common stock for the Chief Financial Officer is a form of executive compensation, representing a related party transaction.

Stakeholder Impact

  • Shareholders: The RSU conversion and subsequent tax-related sale are routine and have a minimal impact on overall share structure or market perception. The reduction in insider ownership due to the tax sale is not typically viewed negatively.
  • Employees: The vesting of RSUs demonstrates the company's executive compensation practices and the realization of long-term incentives.

Key Dates

DateDescription
10/13/2025Grant date of 58,987 restricted stock units to Kevin Williamson.
01/01/2026Conversion of 58,987 restricted stock units into 58,987 shares of common stock.
01/05/2026Disposition of 18,518 shares of common stock to pay tax liability associated with RSU vesting.

Recommendation

hold

This Form 4 filing details a routine insider transaction where the CFO converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations. Such transactions are common for executive compensation and do not typically signal a change in the company's fundamentals or management's long-term outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Tenon Medical, TNON, Kevin Williamson, CFO, Director, Form 4, Insider Trading, RSU, Restricted Stock Units, Stock Sale, Tax Liability, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.